Bone Tumor Ablation Devices Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), by Indication (Osteosarcoma, Chondrosarcoma, Ewing’s Sarcoma, Metastatic Bone Cancer, and Others), by End user (Hospitals, Ambulator

Bone Tumor Ablation Devices Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Others), by Indication (Osteosarcoma, Chondrosarcoma, Ewing’s Sarcoma, Metastatic Bone Cancer, and Others), by End user (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Tumor ablation is a minimally invasive procedure to remove the tumor cells or tissue from the body. Tumor ablation devices consist of a catheter, which is introduced into the tumor under imaging guidance. The use of microwave ablation magnetic image-guiding systems has provided an effective adjunct in laparoscopic ablation, provided better support to surgeons, and increased patient outcomes. Key players are also focused on launching of ablation devices, which is expected to drive the market growth over the forecast period. For instance, in January 2016, Medtronic Plc. launched the OsteoCool radiofrequency ablation system in the U.S. OsteoCool RF Ablation system is a cooled radiofrequency (RF) ablation technology. It offers simultaneous, dual-probe capabilities for treating painful bone tumors.
Market Dynamics
Osteoporosis is a common cause for bone fractures and its prevalence gradually increases with age. For instance, according to the National Center for Biotechnology Information, osteoporosis occurs in 10% men and 13% in women, who are aged 60 years or above. According to the National Osteoporosis Foundation data of 2014, a total of 54 million U.S. adults aged 50 and older were affected by osteoporosis and low bone mass in 2013. It further states that the number of bone fractures will increase by 2 to 4 times by 2020 and 41 million women will suffer from osteoporosis or osteoarthritis. This is mainly attributed to significant rise in geriatric population.
Furthermore, key players in the market are focusing on development of technologically advanced bone tumor ablation devices for treatment of highly prevalent cancer cases and launch them in the market. For instance, in 2018, doctors at Johns Hopkins Medical Center, Baltimore, Maryland reported successful use of AveCure microwave ablation system for the treatment of Metastatic Bone Cancer Bone Cancer Bone Cancer spinal tumors. Moreover, in 2018, doctors at a major hospital in Guadalajara, Mexico reported successful use of AveCure microwave ablation system for the treatment of brain tumors.
Key features of the study:
This report provides in-depth analysis of the global bone tumor ablation devices market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global bone tumor ablation devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global bone tumor ablation devices market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for bone tumor ablation devices market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:
Global Bone Tumor Ablation Devices Market, By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
Global Bone Tumor Ablation Devices Market, By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
Global Bone Tumor Ablation Devices Market, By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Global Bone Tumor Ablation Devices Market, By Region:
North America
By Country:
U.S.
Canada
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Africa
By Country/Region:
South Africa
Central Africa
North Africa
By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Others
By Indication:
Osteosarcoma
Chondrosarcoma
Ewing’s Sarcoma
Metastatic Bone Cancer Bone Cancer Bone Cancer
Others
By End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Company Profiles
Medtronic Plc.*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Merit Medical Systems Inc.
MedWaves Inc.
AngioDynamics Inc.
Olympus Corporation
Varian Medical Systems, Inc.
Mermaid Medical A/S
RF Medical Co., Ltd.
Misomix Inc.
“*” marked represents similar segmentation in other categories in the respective section.